Pregabalin is used in the treatment of central and peripheral neuropathic pain, generalised anxiety disorder, and as an adjuctive treatment for partial seizures (with or without secondary generalisation). The members of the Pregabalin Review Group have all been actively involved in in preclinical or clinical investigations of pregabalin, and present a detailed authoritative and objective review of this poerful pharmacotherapeutic agent.